sacubitril and Metabolic-Syndrome

sacubitril has been researched along with Metabolic-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for sacubitril and Metabolic-Syndrome

Article	Year
[Clinical case: early connection of valsartan/sacubitril in the treatment of hypertension]. Kardiologiia, 2022, May-31, Volume: 62, Issue:5 Metabolic syndrome is a disease the World Health Organization has called a new pandemic of the 21st century. Arterial hypertension is one of the criteria for this diagnosis and a determinant of damage to major target organs. The present clinical case demonstrates an experience of treatment of arterial hypertension associated with metabolic syndrome with a valsartan/sacubitril molecular complex. Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Heart Failure; Humans; Hypertension; Metabolic Syndrome; Stroke Volume; Tetrazoles; Valsartan	2022

Article

Year

[Clinical case: early connection of valsartan/sacubitril in the treatment of hypertension].

Kardiologiia, 2022, May-31, Volume: 62, Issue:5

Metabolic syndrome is a disease the World Health Organization has called a new pandemic of the 21st century. Arterial hypertension is one of the criteria for this diagnosis and a determinant of damage to major target organs. The present clinical case demonstrates an experience of treatment of arterial hypertension associated with metabolic syndrome with a valsartan/sacubitril molecular complex.

Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Heart Failure; Humans; Hypertension; Metabolic Syndrome; Stroke Volume; Tetrazoles; Valsartan

2022